Protect Pharmaceutical (PRTT) Stock Statistics & Valuation Metrics

Protect Pharmaceutical has a market cap or net worth of $27.52M. The enterprise value is -$9.32M.

Protect Pharmaceutical has 57,451,378 shares outstanding. The number of shares has decreased by -2.65% in one year.

Protect Pharmaceutical’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 16.74%.

The current PE Ratio of Protect Pharmaceutical is 4.0. Protect Pharmaceutical’s PEG ratio is 0.03.

In the last 12 months, Protect Pharmaceutical had revenue of 132.26M and earned 56.33M in profits. Earnings per share was 0.98.

In the last 12 months, operating cash flow was 6.18M and capital expenditures -3.49M, giving a free cash flow of 2.69M billion.

Protect Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―

Protect Pharmaceutical upcoming earnings date is ―, ―.

Protect Pharmaceutical as a current ratio of 3.06, with Debt / Equity ratio of 1.27%

In the past 12 months, Protect Pharmaceutical has paid 1.31M in taxes.

Protect Pharmaceutical EV to EBITDA ratio is 0.32, with an EV/FCF ratio of 1.83.

Protect Pharmaceutical has $75.76M in cash and marketable securities with $4.41M in debt, giving a net cash position of $71.36M billion.

Gross margin is 55.70%, with operating margin of 43.58%, and net profit margin of 42.59%.

The average price target for Protect Pharmaceutical is ―, which is 11.43% higher than the current price. The consensus rating is ―